OPKO Health Inc - ESG Rating & Company Profile powered by AI
If you work at OPKO Health Inc and you wish to use your ESG aseessment, please contact us. This ESG score for OPKO Health Inc represents its transparency towards the UN SDGs. This assessment of OPKO Health Inc is prepared by All Street Sevva using proprietary machine learning.
OPKO Health Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.7; made up of an environmental score of 2.7, social score of 4.6 and governance score of 6.7.
4.7
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 816 | Pliant Therapeutics Inc | 4.8 | High |
| 816 | Voyager Therapeutics Inc | 4.8 | High |
| 837 | OPKO Health Inc | 4.7 | High |
| 837 | Bio Rad Laboratories Inc | 4.7 | High |
| 837 | Katakura Industries Co Ltd | 4.7 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does OPKO Health Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes OPKO Health Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes OPKO Health Inc report the average age of the workforce?
Sign up for free to unlockDoes OPKO Health Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes OPKO Health Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes OPKO Health Inc disclose cybersecurity risks?
Sign up for free to unlockDoes OPKO Health Inc offer flexible work?
Sign up for free to unlockDoes OPKO Health Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes OPKO Health Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes OPKO Health Inc conduct supply chain audits?
Sign up for free to unlockDoes OPKO Health Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes OPKO Health Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes OPKO Health Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes OPKO Health Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes OPKO Health Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes OPKO Health Inc disclose water use targets?
Sign up for free to unlockDoes OPKO Health Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid OPKO Health Inc have a product recall in the last two years?
Sign up for free to unlockDoes OPKO Health Inc disclose incidents of discrimination?
Sign up for free to unlockDoes OPKO Health Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas OPKO Health Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes OPKO Health Inc disclose parental leave metrics?
Sign up for free to unlockDoes OPKO Health Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes OPKO Health Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes OPKO Health Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes OPKO Health Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes OPKO Health Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes OPKO Health Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs OPKO Health Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes OPKO Health Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes OPKO Health Inc disclose its waste policy?
Sign up for free to unlockDoes OPKO Health Inc report according to TCFD requirements?
Sign up for free to unlockDoes OPKO Health Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes OPKO Health Inc disclose energy use targets?
Sign up for free to unlockDoes OPKO Health Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes OPKO Health Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for OPKO Health Inc
These potential risks are based on the size, segment and geographies of the company.
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers and governmental units; and a novel diagnostic instrument system to provide blood test results in the point-of-care setting, as well as 4Kscore prostate cancer testing services. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and associated obesity that is in Phase IIb trials; and hGH-CTP, a once-weekly human growth hormone injection that completed Phase III clinical trial in partnership with Pfizer, Inc. This segment develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins. The company also offers specialty APIs; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and imports, markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. In addition, it operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. The company was founded in 1991 and is headquartered in Miami, Florida.